- 5 major GI groups to know
- MB2 Dental adds 5 new partners in 2 months
- Penn Medicine expects $105M ROI from AI
- Arizona spine practice opens ASC
- Oklahoma CRNA charged with misconduct
- 8 health systems, more than $1.4B in capital projects in May
- RFK Jr. visits Summa Health
- Kaiser Permanente plans 11K-square-foot MOB in Nevada
- Dentistry’s AI gold rush
- Community Health Network taps new CFO from Aspirus Health
- California creates $25M fund for at-risk hospitals
- Only 1 in 5 physicians is independent: 10 new numbers behind the collapse
- California physician group acquired by PRISM
- Behavioral health ED visits projected to rise by 1 million
- When your AI agent goes off script: What Moffitt Cancer Center caught early
- Utah physician, 2 nurses charged in $29M fraud scheme
- 3 Ascension CFO moves in 2 days
- The volume paradox costing ASCs millions
- Pediatric radiology leaders launch AI brain tumor dataset
- Inside SCA Health’s clinical nursing ladder — and how it helped cut turnover by 7%
- What ASCs are getting wrong about OR delays — and how to fix it
- 1 behavioral health leader’s playbook for staff retention and safety
- Centene executive to join Froedtert ThedaCare as chief nurse
- Behavioral health ED visits projected to rise by 1 million
- 5 dental AI updates in 1 month
- 3 lawsuit settlements in dentistry
- Financial pressures shutter Iowa dental clinics: 4 notes
- Independent autism research committee adds 7 members
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- 10 notes on the widening DSO performance gap
- CDC-linked autism researcher arraigned on fraud charges
- Nearly 1 in 3 boys under 14 discussed suicide in crisis conversations: Report
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- NYU Langone Health says it received grand jury subpoena over gender-affirming care
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered cardiac risk screening. New CMS reimbursement could unlock a business case for it
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Haleon tackles sports injuries with latest soccer play
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Eating Out Linked To Obesity Risk Worldwide
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- California to award $111M for behavioral health supportive housing
- 6 new psychiatric residency programs to know
- USOSM adds New York practice
- NAMI partners on health crisis preparation hub
- Oklahoma enacts law expanding access to dental care
- Where dentists are leaving value behind in practice sales
- Why dental practices are closing in 2026
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- 988 calls are rising — what’s behind the surge?
- Providence hospital to lay off 40 workers amid behavioral health staffing overhaul
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- University of California, union near May 14 strike deadline with no deal in hand
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- The broken pipeline of mental healthcare for LGBTQ teenagers
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- Watch: 8 Health Insurance Terms You Should Know
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Skil-Care launches specialized healthcare product innovation program
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
A meta-analysis to put the subject of vaccines and autism to rest is long overdue. The public has clearly lost faith in public health authorities' pronouncements after their COVID double takes. It may be necessary to conduct further studies, or redo studies which don't reproduce, as well:
Exclusive: US CDC plans study into vaccines and autism, sources say
By Dan Levine and Leah Douglas - March 8, 2025Summary
* CDC study follows measles outbreak amid declining vaccination rates
* Kennedy's mixed messages on vaccines raise concerns
* Autism rise attributed to broader screening, not vaccinesMarch 7 - The U.S. Centers for Disease Control and Prevention is planning a large study into potential connections between vaccines and autism, two sources familiar with the matter told Reuters, despite extensive scientific research that has disproven or failed to find evidence of such links.
The CDC's move comes amid one of the largest measles outbreaks the U.S. has seen in the past decade, with more than 200 cases and two deaths in Texas and New Mexico. The outbreak has been fueled by declining vaccination rates in parts of the United States where parents have been falsely persuaded that such shots do more harm than good.
U.S. Health Secretary Robert F. Kennedy Jr, whose role includes authority over the CDC, has long sowed doubt over the safety of the combined vaccine for measles, mumps and rubella (MMR). In a cabinet meeting last week, Kennedy initially downplayed news that a school-aged child had died of measles in Texas, the first such death in a decade, calling such outbreaks ordinary and failing to mention the role of vaccination to prevent measles.
Last weekend Kennedy published an opinion piece on Fox News that promoted the role of vaccination, but also told parents vaccination was a personal choice and urged them to consult with their physician.
It is unclear whether Kennedy is involved in the planned CDC study or how it would be carried out. He did not respond to a request for comment.
HHS and CDC cited what they described as skyrocketing autism rates in a joint statement on Friday.
"CDC will leave no stone unturned in its mission to figure out what exactly is happening," the statement said. "The American people expect high quality research and transparency and that is what CDC is delivering."
President Donald Trump's nominee for CDC director, Dr. Dave Weldon, is set for a U.S. Senate committee hearing next week. Some senators have expressed concerns over Weldon's views on vaccines. Weldon declined to comment.
Dr. Wilbur Chen, a professor at the University of Maryland School of Medicine and former member of the CDC's vaccine advisory panel, said the existence of such a study, conducted by the federal government, is itself enough to raise doubts about vaccines among some in the general public.
"It sends the signal that there is something there that is worth investigating, so that means there must be something going on between vaccines and autism," Chen said.
Autism diagnoses in the United States have increased significantly since 2000, intensifying public concern.
Many researchers attribute the rise in diagnoses to more widespread screening and the inclusion of a broader range of behaviors to describe the condition. But some public figures have popularized the idea that vaccines are to blame, an idea stemming from a since-debunked study from British researcher Andrew Wakefield in the late 1990s that connected a rise in autism diagnoses with widespread use of the MMR shot.
The causes of autism are unclear. No rigorous studies have found links between autism and vaccines or medications, or their components such as thimerosal or formaldehyde.
There is widespread speculation among scientists that its neurological characteristics may develop in utero, when the fetal brain is being wired. Studies have linked autism to maternal factors in pregnancy, and some research suggests a link to birth complications and timing.
Trump, in an address to Congress this week, cited the rise in autism among children."So, we're going to find out what it is, and there’s nobody better than Bobby and all of the people that are working with you,” Trump said, referring to Kennedy.
The White House had no immediate comment on the planned CDC study.
Kennedy’s anti-vaccine views have drawn concern among some Republicans. During Kennedy’s confirmation hearing Senator Bill Cassidy, a Louisiana Republican and physician, suggested that the nominee disavow any links between vaccines and autism.
Kennedy denied that he was anti-vaccine, but did not acknowledge that such a link had been debunked.
This week Cassidy questioned Trump’s nominee to lead the National Institutes of Health, Dr. Jay Bhattacharya, over his stance on investigating a potential link between autism and childhood vaccinations.
"I don't generally believe there is a link, based on my reading of the literature," Bhattacharya said. "But we do have a sharp rise in autism rates, and I don't think any scientist really knows the cause of it. I would support a broad scientific agenda based on data to get an answer to that."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















